INSM
Price:
$95.52
Market Cap:
$20.70B
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation...[Read more]
Industry
Biotechnology
IPO Date
2000-06-01
Stock Exchange
NASDAQ
Ticker
INSM
According to Insmed Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 20.87B. This represents a change of -31.72% compared to the average of 30.56B of the last 4 quarters.
The mean historical Enterprise Value of Insmed Incorporated over the last ten years is 6.84B. The current 20.87B Enterprise Value has changed 30.39% with respect to the historical average. Over the past ten years (40 quarters), INSM's Enterprise Value was at its highest in in the December 2025 quarter at 37.44B. The Enterprise Value was at its lowest in in the June 2016 quarter at 411.83M.
Average
6.84B
Median
2.76B
Minimum
710.48M
Maximum
37.44B
Discovering the peaks and valleys of Insmed Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 209.81%
Maximum Annual Enterprise Value = 37.44B
Minimum Annual Increase = -52.60%
Minimum Annual Enterprise Value = 710.48M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 37.44B | 209.81% |
| 2024 | 12.08B | 138.18% |
| 2023 | 5.07B | 98.03% |
| 2022 | 2.56B | -13.13% |
| 2021 | 2.95B | -5.51% |
| 2020 | 3.12B | 61.82% |
| 2019 | 1.93B | 132.49% |
| 2018 | 829.66M | -52.60% |
| 2017 | 1.75B | 146.35% |
| 2016 | 710.48M | -11.65% |
The current Enterprise Value of Insmed Incorporated (INSM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
18.20B
5-year avg
12.02B
10-year avg
6.84B
Insmed Incorporated’s Enterprise Value is less than BeOne Medicines Ltd. (29.98B), less than Agilent Technologies, Inc. (37.80B), less than ResMed Inc. (27.31B), less than IQVIA Holdings Inc. (44.02B), less than Alcon Inc. (35.79B), less than Haleon plc (36.60B), less than Cardinal Health, Inc. (58.31B), less than GE HealthCare Technologies Inc. (37.05B), less than Humana Inc. (53.40B), less than Takeda Pharmaceutical Company Limited (12.09T),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 29.98B | $28.20B | |
| 37.80B | $36.25B | |
| 27.31B | $28.13B | |
| 44.02B | $29.90B | |
| 35.79B | $32.09B | |
| 36.60B | $40.13B | |
| 58.31B | $53.33B | |
| 37.05B | $28.76B | |
| 53.40B | $44.36B | |
| 12.09T | $49.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Insmed Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Insmed Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Insmed Incorporated's Enterprise Value?
What is the highest Enterprise Value for Insmed Incorporated (INSM)?
What is the 3-year average Enterprise Value for Insmed Incorporated (INSM)?
What is the 5-year average Enterprise Value for Insmed Incorporated (INSM)?
How does the current Enterprise Value for Insmed Incorporated (INSM) compare to its historical average?